Bausch + Lomb Corporation (BLCO)
$15.81-1.62%Close
SELLBEAR · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5.6B
- Beta
- 0.56
- P/E (TTM)
- -33.06
- Short % float
- 6.59%
- Days to cover
- 9.8
- SI change
- -6.5%
- 1W
- -7.97%
- 1M
- -10.07%
- vs SPY 1W
- -7.84%
- vs SPY 1M
- -12.57%
Industry peers
FMP comparable companies · ranked by market cap
- PCVXBUYVaxcyte, Inc.$10.3BRECOVERYQ 25$71.38-5.45%
- GKOSBUYGlaukos Corporation$9.8BRECOVERYQ 19$165.69-1.50%
- ARWRSELLArrowhead Pharmaceuticals, Inc.$8.8BCRISISQ 12$62.75-4.28%
- OSCRBUYOscar Health, Inc.$8.7BBULLQ 12$33.37-0.65%
- TGTXSELLTG Therapeutics, Inc.$8.5BBEARQ 11$55.37-1.68%
- ACLXArcellx, Inc.$6.7B$115.07
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$125.12-1.00%
- PTCTSELLPTC Therapeutics, Inc.$5.4BCRISISQ 18$64.70-4.77%
- MMSIBUYMerit Medical Systems, Inc.$5.2BBULLQ 13$87.21-1.79%
- CRSPSELLCRISPR Therapeutics AG$5.1BCRISISQ 20$53.39-2.81%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 61
- VALUE
- 26
- GROWTH
- 52
- GARP
- 90
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC-1.6%
REV YoY-
ROE-2.7%
EPS YoY-
ROA-1.2%
GROSS57
OP7
NET-3
[VALUATION]
P/E TTM-33.06
P/E FWD16.20
SECTOR PE20.34
INDUSTRY PE45.85
P/B0.89
P/FCF-
EV/EBITDA14.01
EV/EBIT-
PEG0.42
FCF YIELD-
RISK
INT COV-
D/E80.22
ALTMAN Z-
CURR RATIO1.55
ND/EBITDA-
BETA0.56
Company news
FAQ
- What is LOPJLB’s current signal on BLCO?
- LOPJLB’s latest quantitative signal on Bausch + Lomb Corporation (BLCO) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is BLCO in?
- Bausch + Lomb Corporation (BLCO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Bausch + Lomb Corporation (BLCO) do?
- Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment al…